Similar articles

• [Therapeutic results with xanthine derivatives in the intermittent claudication syndrome in diabetic patients].

  Gómez Reyes D, Rojas Hidalgo E. Gómez Reyes D, et al. Rev Clin Esp. 1988 Jan;182(1):3-6. Rev Clin Esp. 1988. PMID: 3375512 Spanish. No abstract available.
• [Use of trental and complamine in the microcirculatory disorders of diabetes mellitus].

  Spesivtseva VG, Kasabian IN, Mamaeva GG, Kukes VG. Spesivtseva VG, et al. Sov Med. 1980;(2):64-9. Sov Med. 1980. PMID: 6987747 Clinical Trial. Russian. No abstract available.
• [Teonicol and trental in the treatment of duodenal ulcer].

  Vorob'ev LP, Samsonov AA, Pivovarova EIa. Vorob'ev LP, et al. Sov Med. 1986;(10):98-100. Sov Med. 1986. PMID: 3544244 Clinical Trial. Russian. No abstract available.
• Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.

  Chopra HK, Chopra KL, Aggarwal KK, Parashar SK. Chopra HK, et al. J Med. 1988;19(2):89-107. J Med. 1988. PMID: 3049876 Review.
• Pentoxifylline -- a biomedical profile.

  Müller R. Müller R. J Med. 1979;10(5):307-29. J Med. 1979. PMID: 393789 Review.